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Abstract
Background: This study aimed to characterize blaCTX-M, blaTEM, and blaSHV genes
among extended-spectrum beta-lactamases (ESBLs)-producing Enterobacteriaceae
species in different regions of Sudan.
Methods: In this cross-sectional study, different clinical samples (n = 985) were
collected randomly from symptomatic patients from four geographical regions of Sudan
and cultured on chromogenic media. Following bacterial identification, phenotypic
screening of ESBLs was done according to CLSI guidelines using cefotaxime (30 μg),
ceftazidime (30 μg), and cefepime (30 μg) discs with and without clavulanic acid.
The DNA was extracted by guanidine hydrochloride protocol, and then conventional
PCR was used to detect blaCTX-M, blaTEM, and blaSHV genes. The presence of genes’
subtypes was characterized by DNA Sanger sequencing for selected samples.
Results: Enterobacteriaceae represented 31% (305/985) of all isolates, 42 (128/305)
of which were ESBLs producer, confirmed by phenotypic confirmatory test (75%
[96/128] of them were positive for blaCTX-M genes, 61% [78/128] for blaTEM genes, and
38% [48/128] for blaSHV genes). Fourteen isolates (11%) were negative for all genes.
Forty-eight percent (63/75) of Escherichia coli isolates were positive for blaCTX-M,
while in Klebsiella pneumoniae, the dominant gene was blaTEM (82%) and had a low
amount of blaSHV (59%). There was a significant association (P-value = 0.001 for all
except for chloramphenicol, P = 0.014, and amikacin, P = 0.017) between resistance
to third-generation cephalosporins and ciprofloxacin, nalidixic acid, meropenem,
chloramphenicol, and amikacin. Forty-two percent (40/96) of CTX-M-positive isolates
were in Gizera State, 33% (32.96) in Sinnar, 24% (23/96) in Khartoum, and 1% (1/96) in
White Nile.
Conclusion:We conclude that blaCTX-M genes are the most dominant genes in ESBLs-
producing isolates and are more prevalent in big cities than in rural areas.
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1. Introduction
Extended-spectrum beta-lactamases (ESBLs) are the types of enzymes that cause resis-
tance to most beta-lactam ring containing antibiotics [1]. Enterobacteriaceae sp. can
resist a wide range of antibiotics, including cephalosporin and carbapenems, used as
last-line antibiotics [2]. Infections caused by ESBLs-producing Enterobacteriaceae are
increasingly being reported worldwide, causing high mortality rates, prolonged hospital
stay, and rising medical costs [3]. Escherichia coli and Klebsiella pneumoniae species
are considered among species associated with the high spread of ESBLs genes globally,
especially the blaCTX-M genes, which have become more common in the last 20 years.
Recently, a dramatic increase has been reported in the frequency of blaCTX-M types
β-lactamases-producing bacteria, which replaced the predominant types in the past,
such as blaTEM and blaSHV [4]. blaCTX-M carrier, E. coli, can disseminate these genes in
the community and hospitals from intestinal flora and cause infection [5].
Sudan is one of the many developing countries suffering from irrational use of
antibiotics, where 63% of prescriptions contain antibiotics, and various forms of irrational
cephalosporins usage are noticed [6, 7]. In Sudan, there is no regulation or system
to govern antimicrobial use in humans or animals [8]. Resistance to cephalosporins
and production of ESBLs genes in hospitals and environment have been reported in
previous studies [9–11]. For the first time, this study aimed to detect blaCTX-M, blaSHV,
and blaTEM genes and their subtypes among ESBLs-producing Enterobacteriaceae in
different regions of Sudan.
2. Materials and Methods
A total of 975 clinical samples (n = 985; urine = 951, wound swab = 17, high vaginal
swab = 12, pus = 3, sputum = 2) were collected from four different regions of Sudan
– the Haj Alsafi Teaching Hospital in Khartoum (the capital of Sudan); Wad Madani
Teaching Hospital in Wad Madani City (the second city in Sudan); Wad Alabass Hospital
in Sennar State, Southern Sudan; and Abu Rugba village (remote village) in White Nile
State. All samples were collected randomly from symptomatic patients (hospitalized
or outpatients) during the study period and cultured on Chromogenic agar media
(Liofilchem Co. Italy). Biochemical tests were applied for bacterial identification [12].
Escherichia coli (ATCC25922), Staphylococcus aureus (ATCC29213), and K. pneumonia
(ATCC 700603) were used as quality-control strains.
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2.1. Antimicrobial susceptibility testing
The antimicrobial susceptibility of the selected bacteria was done by the disc-diffusion
technique [13]. The following antibiotic discs were used: amikacin (30 μg), ceftazidime
(30 μg), cefotaxime (30 μg), cefepime (30 μg), chloramphenicol (30 μg), meropenem (10
μg), and nalidixic acid (30 μg) (Liofilchem Co. Italy).
2.2. Phenotypic detection of ESBLs
Phenotypic screening of ESBLs was done according to CLSI guidelines, the following
discs were used: cefotaxime (30 μg), ceftazidime (30 μg), and cefepime (30 μg) discs
with and without clavulanic acid. Phenotypically, ESBLs-positive isolates showed an
increase of ≥5 mm in the zone around discs with clavulanic acid discs compared to the
area around the disc without clavulanic acid [13].
2.3. Identification of extended-spectrum 𝛽-lactamase genes
All positive isolates with phenotypic confirmatory tests were subjected to molecular
screening to detect β-lactamases genes using a conventional PCR machine. DNA
isolation was done by the guanidine hydrochloride method, according to Sabeel et al.
[14]. PCR was carried out using primer sequences presented in Table 1 (Metabion,
Germany) for blaCTX-M, blaTEM, and blaSHV genes [15, 16]. A reaction volume of 25 μl
containing 5 µl Master Mix (iNtRON Biotechnology, Seongnam, Korea), 2 µl DNA, 0.6
μl of each primer, and 16.8 µl DW was used. The PCR steps were firstly subjected to
94°C for 5 min, then 30 cycles (94°C for 45 sec, 57°C for 45 sec, 72°C for 60 sec), and
final elongation at 72°C for 5 min. PCR products were run at 2% agarose gel for bands
detection by UV Transilluminator. Control positive (obtained from previously sequenced
blaCTX-M, blaTEM, and blaSHV genes) and control negative (containing DW, primers, and
Master Mix) were used.
Sanger sequencing was achieved for both directions of DNA products by Macrogen
Company (Seoul, Korea). DNA sequencing was performed for 25 blaCTX-M (7 from Sinnar,
5 from Khartoum, 1 from White Nile, and 12 from Gizera), 3 blaSHV, and 4 blaTEM genes.
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2.4. Statistical analysis
Data were analyzed by the statistical package for social science (SPSS) version 16, using
the Chi-square test. A P-value < 0.05 was considered significant.
3. Results
While 68% (671/985) of the cultured samples showed a significant growth, 32% (314/985)
showed no growth.
Of the 671 isolates, 305 (45.4%) were Enterobacteriaceae isolates (E. coli = 177, K.
pneumoniae = 81, C. freundii complex = 11, Enterobacter species = 19, P. mirabilis = 11,
P. vulgaris = 6); 133 (19.7%) were Enterococcus species; 177 (26.3%) were S. aureus; 19
(2.8%) were Pseudomonas aeruginosa; and 37 (5.5%) were yeast cells.
More than 45% (139/305) of all Enterobacteriaceae isolates were resistant to cefo-
taxime, 39.3% (120/305) to ceftazidime, and 13.4% (41/305) to cefepime. In addition,
92 (30.2%) isolates were resistant to ciprofloxacin, 79 (25.9%) to the nalidixic acid, 21
(6.9%) to meropenem, 99 (32.5%) to chloramphenicol, and 54 (17.7%) to amikacin. There
was a statistically significant (P-value < 0.05) association between resistance to third-
generation cephalosporins and resistance to other antibiotics used in this study (P-value
= 0.001 for all except for chloramphenicol [P = 0.014] and amikacin [P = 0.017]) (Table 2).
3.1. Phenotypic confirmatory test of ESBLs
The occurrence of ESBLs genes was confirmed phenotypically in >41% (128/305) of the
isolates; 54% (54/100) were in Gizera State (Madani), 63.8% (23/36) in Khartoum State
(Haj Alsafi Hospital), 52.1% (48/92) in Sinnar State (Wad Alabas), and 1.3% (1/77) in White
Nile State (Abu Rugba Village) (Table 3). There was a statistically significant (P-value <
0.05) association between ESBLs genes and the different regions of Sudan.
3.2. Genotyping of genes
Of the 128 isolates that showed ESBLs phenotype, 89% (114/128) were positive for ESBLs
genes by PCR; 75% (96/128) were positive for blaCTX-M genes (Figure 1), 42% (40/96) of
which were in Gizera, 33% (32.96) in Sinnar, 24% (23/96) in Khartoum, and 1% (1/96) in
White Nile; 61% (78/128) were positive for blaTEM genes (Figure 2), and 38% (48/128)
were positive for blaSHV genes (Figure 3; Table 4). Twenty-four isolates possessed only
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blaCTX-M genes, seven only blaTEM genes, and one only blaSHV gene. Twenty-six isolates
possessed the three genes together, seven harbored blaTEM and blaSHV genes, twenty-
nine possessed both blaCTX-M and blaTEM genes, and ten harbored blaCTX-M and blaSHV
genes. Moreover, 14 isolates (11%) gave negative results for the three genes.
3.3. DNA sequencing
blaCTX-M−15 represented 78.3% (18/23) of blaCTX-M genes, blaCTX-M−14 13.1% (3/23),
blaCTX-M−27 4.3% (1/23), and blaCTX-M−98 4.3% (1/23). Out of the five blaTEM genes (971
bp), three isolates showed 100% identity with blaTEM−1 (KM598665), while one isolate
(isolate-29) showed 99% identity with blaTEM−1 of E. coli from China (AFI61435). DNA
sequencing was also done for three blaSHV genes (797 bp); two isolates showed 100%
identity (one with blaSHV−28 [ACZ97629] and the other with blaSHV−1 [ACZ97625.1]). The
third isolate showed 98% identity with blaSHV−1 (ACZ97624).
TABLE 1: Primer sequences used in the detection of genes.





















TABLE 2: The association between antibiotic resistance and ESBLs-producing and non-ESBLs-producing
bacteria.






Ciprofloxacin 66 (72%) 26 (28.2%) 0.001
Nalidixic acid 61 (77%) 18 (22.7%) 0.001
Meropenem 17 (81%) 4 (19%) 0.001
Chloramphenicol 70 (71%) 29 (29.2%) 0.014
Amikacin 43 (80%) 11 (20%) 0.017
DOI 10.18502/sjms.v16i1.8933 Page 9
Sudan Journal of Medical Sciences Hisham N Altayb et al
TABLE 3: Phenotypic confirmatory test of ESBLs-producing isolates in different regions of Sudan.
Region Confirmatory test P-value
CTX/CLA CAZ/CLA CPM/CLA
Khartoum (n = 36) 66 (72%) 19 (52.7%) 21 (58.3) 0.001
Gizera (n = 100) 61 (77%) 45 (45%) 44 (44) 0.001
Sinnar (n = 92) 17 (81%) 43 (46.7%) 44 (47.8) 0.0001
White Nile (n = 77) 70 (71%) 1 (1.3%) 1 (1.3) 0.0001
Total (n = 305) 43 (80%) 108 (35.4%) 110 (36) 0.0001
CAZ: ceftazidime; CTX: cefotaxime; CPM: cefepime; CLA: clavulanic acid; ESBLs: extended spectrum
beta-lactamases
TABLE 4: Frequency of CTX-M TEM and SHV genes among ESBLs-producing Enterobacteriaceae isolates.
Isolate CTX-M TEM SHV
E. coli (n = 75) 63 (84%) 42 (56%) 24 (32%)
K. pneumoniae (n = 34) 21 (62%) 28 (82%) 20 (59%)
Enterobacter sp. (n = 7) 5 (71%) 4 (57%) 1 (14%)
P. mirabilis (8) 4 (50%) 3 (38%) 2 (25%)
P. vulgaris (1) 1 (100%) 0 (0%) 1 (100%)
C. freundii complex (n = 3) 2 (66%) 1 (33%) 0 (0%)
Total (n = 128) 96 (75%) 78 (61%) 48 (38%)
Figure 1: PCR amplification of CTX-M genes. Lane 1 DNA marker (100–1500 bp), lane 2 positive control,
lane 3 negative control, lanes 4–10 were positive for CTX-M genes (550 bp).
4. Discussion
Several studies exhibited that the prevalence of ESBL-producing bacteria is a serious
problem of global public health, and their distribution can be varied according to
geographic region, country, and studied institution [17, 18].
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Figure 2: Amplification of TEM genes. Lane 1 DNA marker (100–1500bp), lane 2 positive control, lanes 3–5
were positive for TEM (971 bp), lanes 6–10 are negative samples.
Figure 3: PCR amplification of SHV genes separated. Lane 1 DNAmarker: MW 100–1500 bp, lane 2 positive
control, lanes 3–9 were positive for SHV genes (797 bp), lane 10 is negative control.
In this study, we report the increasing rates of ESBLs-producing Enterobacteriaceae
compared to other previous study conducted in Khartoum State by Mekki et al. [19],
we recorded ESBLs production among Klebsiella sp. and E. coli isolated as 53% in
2010. Moreover, Ahmed et al. [20] had recorded ESBLs production among Enterobac-
teriaceae sp. as 59.6% in 2013. This finding in the Sinnar State is higher than that
previously reported in 2012 by Hamedelnil and Eltayeb [21], who reported that 36% of
133 isolates were ESBLs producers.
In the current study, we report that resistance to cefotaxime (45%) is higher than
that to ceftazidime (39.3%) and cefepime (13.4%). We also observed a high ceftazidime-
resistant rate (39.3%) within CTX-M-positive isolates, which may be because we report
high frequencies of blaCTX-M genes in our isolates. Previous reports indicated several
types of blaCTX-M genes exhibiting an increased enzymatic activity against ceftazidime
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[22, 23]. A high resistance rate was observed in this study to ciprofloxacin, nalidixic acid,
meropenem, chloramphenicol, and amikacin within ESBLs-producing isolates. There
was statistically significant (P-value < 0.05) association between resistance to third-
generation cephalosporins and these antibiotics (P-value = 0.001, 0.001, 0.001, 0.014,
and 0.017, respectively). The possible cause for this phenomenon may be that ESBLs are
encoded on mobile plasmids, facilitating its transmission from one organism to another
[24].
Furthermore, 89% (114/128) of ESBLs-positive isolates by phenotypic detection were
also positive by PCR; blaCTX-M genes were positive in 75% (96/128), blaTEM genes in
61% (78/128), and blaSHV genes in 38% (48/128). This finding agrees with Hamedelnil
and Eltayeb [21] and Omar et al. [20], who reported that blaCTX-M genes were the most
dominant genes followed by blaTEM and blaSHV genes. High frequencies of blaSHV genes
(67.4%) were reported in other studies; Feizabadi et al. [25] reported genes encoding
the ESBLs, including blaSHV and blaCTX-M among 89 K. pneumonia isolates by PCR.
There were 14 isolates (11%) that gave negative results by PCR but positive by phe-
notypic test for ESBLs; this may be due to other ESBLs genes that were not covered
by our primers sets. Many studies have confirmed the presence of other ESBLs genes
in Enterobacteriaceae like blaVEB-1, blaOXA, and blaPER or may be due to the presence
of another mechanism of resistance [26, 27]. Furthermore, 19 ESBLs-positive isolates
harbored only blaTEM and blaSHV genes; some of these genes were blaTEM-1, and blaSHV-1
and ESBLs phenomenon may arise from another mechanism of resistance.
In the present study, we observed that the cephalosporin-resistance rate and produc-
tion of ESBLs genes were higher in urban cities compared to rural areas. In Khartoum,
64% (23/36) of the isolates were resistant to cephalosporin, 54% (54/100) in Madani
(Gizera State), and 51% (48/94) in Wad Alabass locality (Sinnar State), while in rural areas
such as Abu Rugba village, they were much lower (2.6 % [2/76]). This difference may
be because cities are more crowded than rural areas, which facilitates ESBLs spread.
Also, antibiotic consumption is higher in cities than in rural areas due to easy access
to hospitals and pharmacies, and this is observed in the result of Abu Rugba village,
where there is no pharmacy or hospital. Unfortunately, in Sudan, cephalosporins and
other antibiotics are sold as over-the-counter medication, explaining the overuse of
antibiotics [6, 7].
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Limitations
Limited resources prevented us from sequencing all amplified genes, and we selected
some samples from different regions to be used as control strains to give us a general
idea about the common gene subtypes.
5. Conclusions
This study has shown a high prevalence of ESBLs-producing bacteria in different regions
of Sudan, especially in big cities than in rural areas. blaCTX-M genes are the most domi-
nant genes in ESBLs-producing isolates. This alarming situation of explosive spreading
of ESBLs genes, especially blaCTX−𝑀 -producing isolates, highlights the need for their
epidemiological monitoring. Integrated and regular management of antibiotic consump-
tion needs to be monitored in our society to limit their spread.
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